EDWARDS LIFESCNS (EWL BE) stock market data APIs
€62.7561
0(0%)
as of October 16, 2025
Try our APIs with
free plan!
EDWARDS LIFESCNS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EWL.BE.
Prev. Close
62.7561
Open
62.7561
High
62.7561
Low
62.7561
52 wk Range
59.62-72.63
Market Cap
67 356 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EDWARDS LIFESCNS data using free add-ons & libraries
Get EDWARDS LIFESCNS Fundamental Data
EDWARDS LIFESCNS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EDWARDS LIFESCNS News
New
Global Undervalued Small Caps With Insider Action To Watch In October 2025
Amidst the backdrop of renewed U.S.-China trade tensions and concerns over a prolonged U.S. government shutdown, global markets have experienced notable volatility, with key indices such as the S&P 60...
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
Pulse Biosciences PLSE recently reported encouraging late-breaking data from the first-in-human feasibility study of its nPulse Cardiac Surgical System. The study data were unveiled at the 39th Europe...
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus
Abbott Laboratories ABT is slated to report third-quarter 2025 results on Oct. 15, before the opening bell. The company delivered adjusted earnings per share (EPS) of $1.26 in the last quarter, which...
Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline
Edwards Lifesciences (EW) has seen its stock trend lower over the past month, down about 6%. Investors are keeping an eye on recent performance and fundamentals as they review the company’s latest r...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
